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515 - 5equence-based typing: linking epidemiology .•.
ITuS181 VanA gene duster typing for monitoring the spread of
glycopeptide resistance In enterococci
W. Witte. G. Werner. I. Klare
Robert Koch [tlstitute, WertJigerode Bratlch, 38855 WertJigerode, Germatly
Objective: To answer the question whether dissemination of glycopeptide
resistance in enterococci is due to clonal spread ofstrains, spread ofparticular
conjugative plasmids or frequent spreading of the vatlA gene cluster.
Methods: Molecular typing of enterococcal strains by macrorestriction
patterns. of plasmids by restriction fragment length polymorphism and
random primed PCR of the vanA gene cluster by overlapping PCR.
Results: The majority of glycopeptide resistant E. faeeium is polyclonal and
the vanA gene cluster can be discriminated by overlapping PCR. The same
subtypes of the vanA gene cluster are found in different GREF clons of
different ecological and epidemiological origin (strains from animals.
humans in the community and from hospitals. On the other hand GREF
with identical macrorestriction patterns can harbour different conjugative
plasmids carrying different polymorphs of the vanA gene cluster.
Conduslons: The spread of glycopeptide resistance among E. faecium is
rather likely due to dissemination of the vatlA gene cluster among a variety
of different strains. GREF with identical macrorestriction patterns suggest-
ing an interhospital spread might have acquired vanA by independent
events.
ITuS171 Multilocus sequence typing of bacterial pathogens -
what have we leamed?
Mark C. Enright
Wellcome Trust Centre for the Epidemiology of Infectious Disease, University of
Oxford, Oxford, Utlited Kingdom
Introduction: Multilocus sequence typing (MLST), first applied to study
Neisseria meningitidis has also been used to characterize the population
biology and global epidemiology of organisms such as S. pneumoniae, and
S. aureus from invasive disease. The technique relies on determining the
DNA sequence for seven housekeeping gene fragments (-500 bp) before
assigning allele numbers at each locus to provide each isolate with an allelic
profile or sequence type (ST). MLST data can be stored and queried via the
internet at http://mlst.zoo.ox.ac.uk, allowing workers around the world to
compare STs oflocally important isolates with those on the database. MLST
is being used to characterize the epidemiology and population biology of
many bacterial pathogens.
Streptococcus pneumoniae The STs ofover 600 isolates from disease and
carriage are deposited on the MLST database. including examples of all
major multiply drug-resistant clones described to date, including the Spanish
23F. 6B and 9V clones. MLST has been used to characterize novel major
clones found in the United Kingdom and several other countries, and was
used to detect two new multidrug resistant lineages from Taiwan.
Staphylococcus aureus MLST has been used to analyze 155 isolates from
community-acquired disease in the Oxford area as well as 179 isolates from
carriage and the distinct population structures found show that clear genetic
differences exist between these two populations. MLST studies on MRSA
isolates from around the world show that some ofthe major MRSA lineages
described to date are very closely related and share a common origin as do
isolates ofepidemic MRSA 3 commonly found in the UK and GISA isolates
from the USA.
MLST is adding greatly to our knowledge of the epidemiology of
bacterial pathogens and databases for individual pathogens, which are
publicly available online, are providing a valuable resource workers in this
field.
[TUS2O] Molecular variability of pathogenicity Islands from
pathogenic Escherichia coli
J. Hacker, G. Blum-Oehler. U. Dobrindt, B. Middendorf, T. Olschlager,
H. Karch
University of Wiirzburg, Wiirzburg, Germany
Pathogenic variants of Escherithia coli may be responsible for extraintestinal
as well as for intestinal infections. Virulence-associated genes of pathogenic
E. coli, encoding toxins, adherence factors, iron uptake systems or secretion
pathways may be located on pathogenicity is12nds (PAis). The majority of
PAis are part of the chromosomes, particular PAis, however, may be also
part of mobile genetic elements such as plasmids and bacteriophages. We
have analysed the composition of PAis from uropathogenic E. coli (UPEC)
as well as from enterohemorrhagic E. coli variants (EHEC). While the
majority of PAis are pathotype specific, the so called "high pathogenicity
island" (HPI). first described for pathogenic strains ofYersinia may be part
of the genome ofvarious E. coli pathotypes. This indicates a transfer of these
specific PAis between different strains. In addition, loss of PAls, due to
deletion formation occurs. Both events, transfer and deletion contribute to
the variability of the different E. coli pathotypes. In addition. the sequence
composition of the different PAis, differs between islands of different
pathotypes. Therefore, the presence of PAis as well as the composition of
PAl specific sequences could be used as epidemiological markers to distin-
guish between different pathotypes ans strains of the enterobacteria.
516 - Prevention and treatment of HIV
[TuS241lmmune reconstitution in HIV
J. D. Lundgren
Department of I'ifec/ious Diseases, Hvidovre University Hospital, Copenhagen,
Denmark
ObjectIve: The hallmark in the pathogenesis of the HIV infection is the
depletion ofCD4 positive lymphocytes leading to severe combined immu-
nodeficiency. This talk will discuss the pathogenesis of HIV-related immu-
nodeficiency, and how therapy may reverse this process.
Results: HIV infects and destroys CD4 + lymphocytes, and as these cells are
decreasing to levels below 200 cells/ttL in peripheral blood, opportunistic
infections begin [0 emerge. The depletion is the result ofdecreased produc-
tion. increased destruction, and entrapment of the cells in the lymphnodes.
Upon initiation of combination antiretroviral therapy (CAT), a rapid
increase in the CD4 + cell count occurs over the first 4 weeks, followed
by a slower increased in the following months. Complete recovery of
immune function to normal levels appears not to occur. However, recent
research has demonstrated that patients experiencing a rebound in CD4 +
cell count induced by CAT, has a markedly decreased risk of developing
clinical disease. Chemoprophylaxis to prevent opportunistic infections can
be safely discontinued in this situation. A fully suppressed viral replication by
CAT is not necessary for the rebound of the CD4+ cell count. Adjunctive
interleukin-2 (IL-2) may funher improve immune function and possibly
assist in controlling the HIV infection. This drug markedly increases the
proliferation of CD4 cells. Whether these CD4 cells are clinically fully
functional is currently being assessed in phase ill trials.
Condusion: It is possible to reverse the immunodeficiency induced by HIV
by use of combination antiretroviral therapy. The role of interleukin-2 as
adjunctive therapy is currently being investigated.
517 - Use of cytokines and cytokine antagonists in ...
ITuS27I Immunotherapeutic approaches In Invasive
Aspergillus infections
E. Roilides
3rd Dept ofPediatrics, Aristotle Univ., Thessaloniki, Greece
Invasive aspegillosis (IA) has become a major complication in immunocom-
promised patients. In addition to Aspergillus jUmigatus, the most common
cause of IA. other Aspergillus spp. can cause invasive infections with high
mortality. Recent studies examining the immunopathogenesis of IA have
provided increased insights into the relative importance of the different
compartments of host immune defenses against Aspergillus spp. such as
macrophages, neutrophils, T helper I and 2 as well as NK lymphocytes. In
parallel. a number ofimmunocnhancing cytokines have been discovered and
several studies of their involvement in antifungal host defenses both in vitro
and in animal models of IA have been published. Due to their ability to
upregulate phagocyte number and/or function, the cytokines of greatest
interest are granulocyte colonystimulating factor, granulocyte-macrophage
colony-stimulating factor, macrophage colony-stimulating factor, inter-
feron-')'. interleukin-I and tumor necrosis factor..... Adjuvant use of these
cytokines may be ofvalue for lA, although a clinical benefit to patients is still
limited to few studies and indications. In addition, reconstitution ofimmune
response by transfusion of large numbers of allogeneic phagocytes pre-
viously stimulated with hemopoietic cytokines (Le. G-CSF) has shown
preliminary beneficial role on the management of refractory fungal infec-
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tions including IA. Th2 cytokines, i.e. interleukin-4 and -10, have down-
regulatory effects on antifungal phagocytic activity against A. fumigatus.
Neutralization of these cytokines and their immunosuppressive function has
beneficial effects on murine models of IA. The in virro and in vivo
demonstrations of improved outcome of IA by the regulation of these
cytokines offer novel approaches in the management of this serious infection
in immunocompromised patients. Further evaluation of safety and efficacy
of these immunotherapeutic modalities is a new and promising area for
research.
518 - Resistant pneumococci. what we have learnt •..
[fuS3Ol What Is pneumococ:cal resistance? The role of
pharmaco-dynamics in determination of breakpoints
Niels Frimodt-Moller
Dept. o.fClinical Microbiology, Statens Serum Institut, Copenhagen, Denmark.
Penicillin resistance in pneumococci is caused by mutations in the genes
coding for the penicillin-binding proteins (PBP) leading to reduced affinity
for binding of the antibiotics to the PBP's. Additionally changes may take
place in other enzyme systems not related to the PBP's. Increasing number of
mutations in PBP's, or changes due to transformation, leads to increasing
MIC's of beta-lactam antibiotics, while the activities of all other antibiotics
are unaffected. The killing effect of penicillin at similar multiples of the
MIC's is usually the same in susceptible (PSP) and resistant (PRP)strains. If
PBP2x is altered. tolerance towards penicillin may develop. The higher
MIC's have the consequences. that increasing sizes of doses of beta-Iactam
antibiotics are necessary. A clear-cut breakpoint is difficult to define with the
stepwise increase in MIC's. The limit for effect in vivo will be when the
necessary dose to achieve active concentrations at the site ofinfection exceeds
the tolerance of the host. Thus, treating meningitis is problematic due to the
difficulty of beta-lactams to penetrate the blood-brain barrier. Optimal use
of pharmacodynamic principles can, however, reduce the size of the dose
necessary for effect against PRP. It is now clear from various experimental
animal models, that the pharmacokinetic parameters governing the effect in
vivo for penicillins against PSP, i.e. the time> MIC, is the same for PRP's.
Those beta-lactams that have the highest activity against PRP's and that can
achieve high and sustained non-proteinbound concentrations at the site of
infections will therefore have decisive roles in treatment of PRP's. Also,
certain drug combinations can be of benefit against srrains with high MIGs.
ITuS31I Antibiotic treatment Does it make a dierence? The
search for new end points in dinical trials
C. Carbon
Hopital Bichat, Paris, France
Two questions regarding infections in which Streptococcus pneumoniae may
be involved are (i) is antibiotic (AB) treatment always necessary in common
respiratory rract infections (RTis)? (ii) what is the incidence of resistance to
AB on outcome and therapeutic strategies? S. pneumoniM is involved in
different R Tis and may induce severe complications. It is suspected in the
presence of evident clinical symptoms with high fever. Reduced suscept-
ibility to penicillin in R Tis is overcome by increasing amoxicillin doses.
Resistance to macrolides or TMP/SMZ is accompanied by clinical failures.
Clinical trials should only include patients at high risk ofbeing infected by a
pneumococcus and actually needing AB, with discussion of the diagnostic
procedures to get the organism. In phase 2 trials those investigations are
mandatory to establish the intrinsic activity ofthe new drug. In phase 3 trials,
the need for investigations should be based on the current practices for the
given infection. Strong evaluation criteria should be retained to perform an
objective evaluation of the potentialities of the drug. This is easier if only
severe infections are considered. Careful analysis offailures should be made,
along with serum drug levels. Susceptibiliry ofpersisting organisms must be
compared to that of the initial strain. This helps define in vivo breakpoints.
As it is difficult to achieve these goals in clinical trials, in virro and animal
studies on the potential of the new drug to select high level resistant variants
and defmc the limit of the recommended regimens on efficacy are needed.
519 - Intraabdominal infections
ITuS34! Open management of diuse peritonitis
T.Hau
Nordwest-Krankenhaus Sande, Germany
Even though open management of peritonitis is done frequently the
recommendation for its use is based on case series or non-randomized
historic cohort studies. Prospective studies do not show any advantage
over closed techniques. On the basis ofa prospective multicenter study in 334
patients we performed a case controlled study comparing planned re-
laparotomy (PL) to relaparotomy on demand. The matching was based
on the age of the patient, the number of coexisting diseases, the acute
physiology, Score" and the secure source control all ofwhich were found to
be significant prognostic factors. There was no difference in mortality, MOF
and infectious complications due to suture leaIts, recurrent intraabdominal
infections and septicemia were more common after Pi. Some variables in
the PL group, however, indicated that there might be certain subgroups of
patients which may benefit from this procedure and that technical details of
the procedure are important.
In summary, indications for PL should be made with caution. The most
likely patients to benefit from the procedure will be those in whom a proper
peritoneal toilet cannot be performed at the first operation and those who are
in danger of developing an abdominal compartment syndrom.
520 - Management of immunocompromised hosts
with ...
ITuS38I Imaging techniques for early detection and dlerential
diagnosis of pulmonary infiltrates
C. P. Heussel l , H. -U. Kauczor l , A. J. Ullmann2
tDepartment of Radiology; 2111. Medical Department ofMedicine,johlllUres
Gutenberg-University Mainz, Germany
The two major tasks of radiographic imaging in patients with suspected
pneumonia are (1) eady detection including localisation of pulmonary
infiltrates and (2) characterisation of infiltrates for distingnishing between
non-infectious and infectious aetiologies.
Chest radiography (CR) is useful in immunocompetent patients for
detection and follow-up of bacterial pneumonia. However, in immuno-
compromised hosts, during the early phase of infection, CR may fail in
about 50% of the cases to detect an atypical pneumonia. Therefore. more
sensitive methods arc frequently applied. High-resolution computed tomo-
graphy (HRCn, which is the most sensitive technique of computed
tomography to identify infiltrates early on, can safely distinguish between
acute inflammation and non-inflammatory conditions such as scar or
atelectasis. Therefore, CT became the gold standard in chest imaging,
especially in immunocomprornised hosts. CT-scanners are widely available.
The technical requirements and the costs of HRCT and CT are low in
comparison to antibiotics. The radiation dose is about 8-10 fold higher than
in CR (spiral-CT: ~50x). Further techniques are discussed. Pattern recog-
nition in HRCT assists in determining the differential diagnoses. Bacterial.
fungal and viral pneumonia as well as pulmonary congestion, Iymphangio-
sis, graft-versus host disease. graft-rejection and radiation toxicity appear
frequently with specific findings on HRCT.1n comparison to bronchoscopy
and surgery, HRCT is a non-invasive method and offers the clinician
immediately available information for diagnosing a possible underlying
disease. However, this information can be helpful in establishing a diagnosis
but is not always verifiable. Experience, local epidemeology and clinical
information are necessary for the characterisation ofinfiltrates in immuno-
compromised hosts.
ITuS421 Options and limitations of a surgical approach In
patients with invasive pulmonary aspergillosis
M. Tamm
Pneumology, University Hospital Basel, Switzerland; Institute of Re.<piratory
Medicine, University ifSydney, Au.<tralia
Invasive pulmonary aspergillosis (IPA) is a frequent complication in neu-
tropenic patients and associated with a very high mortality. Diagnosis oflPA
is usu:111y based on antibiotic resistant fever combined with localised
infiltrates on CT scan developing in neutropenic patients. Broncboalveolar
